These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 7509950)
1. Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle. Davenport AP; O'Reilly G; Molenaar P; Maguire JJ; Kuc RE; Sharkey A; Bacon CR; Ferro A J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S22-5. PubMed ID: 7509950 [TBL] [Abstract][Full Text] [Related]
2. Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type. Davenport AP; O'Reilly G; Kuc RE Br J Pharmacol; 1995 Mar; 114(6):1110-6. PubMed ID: 7620699 [TBL] [Abstract][Full Text] [Related]
3. ETA and ETB endothelin receptors in human myometrium characterized by the subtype selective ligands BQ123, BQ3020, FR139317 and PD151242. Bacon CR; Morrison JJ; O'Reilly G; Cameron IT; Davenport AP J Endocrinol; 1995 Jan; 144(1):127-34. PubMed ID: 7891013 [TBL] [Abstract][Full Text] [Related]
4. Endothelin receptors in human coronary artery and aorta. Bacon CR; Davenport AP Br J Pharmacol; 1996 Mar; 117(5):986-92. PubMed ID: 8851522 [TBL] [Abstract][Full Text] [Related]
5. [125I]-PD151242: a selective ligand for endothelin ETA receptors in human kidney which localizes to renal vasculature. Davenport AP; Kuc RE; Hoskins SL; Karet FE; Fitzgerald F Br J Pharmacol; 1994 Dec; 113(4):1303-10. PubMed ID: 7534185 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart. Peter MG; Davenport AP Br J Pharmacol; 1996 Feb; 117(3):455-462. PubMed ID: 8821534 [TBL] [Abstract][Full Text] [Related]
7. Endothelin ETA receptor expression in human cerebrovascular smooth muscle cells. Yu JC; Pickard JD; Davenport AP Br J Pharmacol; 1995 Nov; 116(5):2441-6. PubMed ID: 8581282 [TBL] [Abstract][Full Text] [Related]
8. Characterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissues. Davenport AP; Kuc RE; Ashby MJ; Patt WC; Doherty AM Br J Pharmacol; 1998 Jan; 123(2):223-30. PubMed ID: 9489609 [TBL] [Abstract][Full Text] [Related]
9. [125I]-PD151242: a selective radioligand for human ETA receptors. Davenport AP; Kuc RE; Fitzgerald F; Maguire JJ; Berryman K; Doherty AM Br J Pharmacol; 1994 Jan; 111(1):4-6. PubMed ID: 8012722 [TBL] [Abstract][Full Text] [Related]
10. Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro. Maguire JJ; Kuc RE; O'Reilly G; Davenport AP Br J Pharmacol; 1994 Sep; 113(1):49-54. PubMed ID: 7812631 [TBL] [Abstract][Full Text] [Related]
11. Human kidney: endothelin isoforms detected by HPLC with radioimmunoassay and receptor subtypes detected using ligands BQ123 and BQ3020. Karet FE; Davenport AP J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S29-33. PubMed ID: 8121179 [TBL] [Abstract][Full Text] [Related]
12. Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart. Molenaar P; Kuc RE; Davenport AP Br J Pharmacol; 1992 Nov; 107(3):637-9. PubMed ID: 1472961 [TBL] [Abstract][Full Text] [Related]
13. Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney. Karet FE; Kuc RE; Davenport AP Kidney Int; 1993 Jul; 44(1):36-42. PubMed ID: 8355464 [TBL] [Abstract][Full Text] [Related]
14. Characterization of [125I]-endothelin-1 and [125I]-BQ3020 binding to rat cerebellar endothelin receptors. Widdowson PS; Kirk CN Br J Pharmacol; 1996 Aug; 118(8):2126-30. PubMed ID: 8864551 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of the rat cerebellar endothelin B (ETB) receptor using the novel agonist radioligand [125I]BQ3020. Jarvis MF; Assal AA; Gessner G Brain Res; 1994 Nov; 665(1):33-8. PubMed ID: 7882015 [TBL] [Abstract][Full Text] [Related]
16. ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Maguire JJ; Davenport AP Br J Pharmacol; 1995 May; 115(1):191-7. PubMed ID: 7647976 [TBL] [Abstract][Full Text] [Related]
17. Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Molenaar P; O'Reilly G; Sharkey A; Kuc RE; Harding DP; Plumpton C; Gresham GA; Davenport AP Circ Res; 1993 Mar; 72(3):526-38. PubMed ID: 7679333 [TBL] [Abstract][Full Text] [Related]
18. Characterization of endothelin receptors in human brain cortex, gliomas, and meningiomas. Harland SP; Kuc RE; Pickard JD; Davenport AP J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S408-11. PubMed ID: 8587429 [TBL] [Abstract][Full Text] [Related]
19. Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: possible formation of an ETA-ETB receptor heterodimer. Harada N; Himeno A; Shigematsu K; Sumikawa K; Niwa M Cell Mol Neurobiol; 2002 Apr; 22(2):207-26. PubMed ID: 12363203 [TBL] [Abstract][Full Text] [Related]
20. Endothelin receptors mediating functional responses in human small arteries and veins. Riezebos J; Watts IS; Vallance PJ Br J Pharmacol; 1994 Feb; 111(2):609-15. PubMed ID: 8004404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]